Richard D. Katz - 01 Feb 2022 Form 4 Insider Report for Allena Pharmaceuticals, Inc.

Role
Chief Financial Officer
Signature
/s/ Kevin Brennan, attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Feb 2022
Net transactions value
$0
Form type
4
Filing time
02 Feb 2022, 15:15:22 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNAQ Restricted Stock Units Award $0 +255,000 $0.000000 255,000 01 Feb 2022 Common Stock 255,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units were granted pursuant to a retention plan approved by the board of directors of the Issuer.
F2 The restricted stock units will vest ratably in equal installments on July 15th and January 15th of each year over the three-year period immediately following February 1, 2022, and will accelerate in full upon the consummation of a change in control, in each case, subject to the Reporting Person's continued service through each applicable vesting date.